MARKET

EDAP

EDAP

Edap Tms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.330
+0.040
+1.75%
Closed 16:00 03/27 EDT
OPEN
2.340
PREV CLOSE
2.290
HIGH
2.380
LOW
2.180
VOLUME
109.89K
TURNOVER
--
52 WEEK HIGH
5.42
52 WEEK LOW
1.460
MARKET CAP
67.57M
P/E (TTM)
17.81
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EDAP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EDAP stock price target is 6.11 with a high estimate of 6.62 and a low estimate of 5.60.

EPS

EDAP News

More
  • Week 14 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
  • Seeking Alpha - Article · 1d ago
  • EDAP TMS SA to Announce Fourth Quarter and Year Ended December 31, 2019 Financial Results on Monday, March 30, 2020
  • GlobeNewswire · 5d ago
  • EDAP Issues Letter to Shareholders Providing an Update on COVID-19 and the Potential Impact to Operations
  • GlobeNewswire · 03/17 13:35
  • The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
  • Benzinga · 03/12 11:37

Industry

Advanced Medical Equipment & Technology
-2.20%
Healthcare Equipment & Supplies
-1.86%

Hot Stocks

Symbol
Price
%Change

About EDAP

EDAP TMS S.A. (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors. The Company also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries. The HIFU division is engaged in the development, manufacturing and marketing of medical devices based on HIFU technology for the invasive treatment of urological and other clinical indications. The UDS division is engaged in the development, marketing, manufacturing and servicing of medical devices for the invasive diagnosis or treatment of urological disorders, urinary stones, and other clinical indications.
More

Webull offers kinds of Edap Tms SA (ADR) stock information, including NASDAQ:EDAP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDAP stock news, and many more online research tools to help you make informed decisions.